Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

[Metabolic syndrome as the risk factor for ischaemic stroke].

Lukasik M, Kozubski W.

Neurol Neurochir Pol. 2012 May-Jun;46(3):271-8. Review. Polish.

PMID:
22773514
2.

Validation of metabolic syndrome score by confirmatory factor analysis in children and adults and prediction of cardiometabolic outcomes in adults.

Viitasalo A, Lakka TA, Laaksonen DE, Savonen K, Lakka HM, Hassinen M, Komulainen P, Tompuri T, Kurl S, Laukkanen JA, Rauramaa R.

Diabetologia. 2014 May;57(5):940-9. doi: 10.1007/s00125-014-3172-5. Epub 2014 Jan 24.

PMID:
24463933
3.

Metabolic syndrome and its components as risk factors for first-ever acute ischemic noncardioembolic stroke.

Maruyama K, Uchiyama S, Iwata M.

J Stroke Cerebrovasc Dis. 2009 May-Jun;18(3):173-7. doi: 10.1016/j.jstrokecerebrovasdis.2008.03.008.

PMID:
19426885
4.

Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack.

Scott DP, Greenfield JR, Bramah V, Alford J, Bennett C, Markus R, Campbell LV.

Intern Med J. 2010 Apr;40(4):275-80. doi: 10.1111/j.1445-5994.2009.01941.x. Epub 2009 Mar 9.

PMID:
19383060
5.
6.

Impact of metabolic syndrome on the prognosis of ischemic stroke secondary to symptomatic intracranial atherosclerosis in Chinese patients.

Mi D, Zhang L, Wang C, Liu L, Pu Y, Zhao X, Wang Y, Wang Y.

PLoS One. 2012;7(12):e51421. doi: 10.1371/journal.pone.0051421. Epub 2012 Dec 10.

7.

Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.

Protack CD, Bakken AM, Xu J, Saad WA, Lumsden AB, Davies MG.

J Vasc Surg. 2009 May;49(5):1172-80.e1; discussion 1180. doi: 10.1016/j.jvs.2008.12.011.

8.
9.

Metabolic syndrome increases oxidative stress but does not influence disability and short-time outcome in acute ischemic stroke patients.

Simão AN, Lehmann MF, Alfieri DF, Meloni MZ, Flauzino T, Scavuzzi BM, de Oliveira SR, Lozovoy MA, Dichi I, Reiche EM.

Metab Brain Dis. 2015 Dec;30(6):1409-16. doi: 10.1007/s11011-015-9720-y. Epub 2015 Sep 5.

PMID:
26342606
10.

Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.

Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M; WASID Study Group.

Neurology. 2006 May 9;66(9):1344-9.

PMID:
16682665
11.

Association between metabolic syndrome and previous ischemic lesions in patients with intracranial atherosclerotic stroke.

Park JH, Kwon HM.

Clin Neurol Neurosurg. 2008 Mar;110(3):215-21. Epub 2007 Dec 4.

PMID:
18055103
13.

Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.

Jackson KG, Walden CM, Murray P, Smith AM, Minihane AM, Lovegrove JA, Williams CM.

Metabolism. 2013 Aug;62(8):1065-9. doi: 10.1016/j.metabol.2013.03.001. Epub 2013 Apr 15.

PMID:
23598085
14.

Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events.

Solbu MD, Kronborg J, Jenssen TG, Njølstad I, Løchen ML, Mathiesen EB, Wilsgaard T, Eriksen BO, Toft I.

Atherosclerosis. 2009 Jun;204(2):503-8. doi: 10.1016/j.atherosclerosis.2008.11.002. Epub 2008 Nov 12.

PMID:
19091314
15.

Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases.

Wassink AM, van der Graaf Y, Janssen KJ, Cook NR, Visseren FL; SMART Study Group.

Eur J Prev Cardiol. 2012 Dec;19(6):1486-95. doi: 10.1177/1741826711426636. Epub 2011 Oct 18.

PMID:
22008749
16.

Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.

Shand BI, Scott RS, Lewis JG, Elder PA, Frampton CM.

Int J Obes (Lond). 2009 Nov;33(11):1274-9. doi: 10.1038/ijo.2009.169. Epub 2009 Sep 1.

PMID:
19721448
17.

Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.

Milionis HJ, Kostapanos MS, Liberopoulos EN, Goudevenos J, Athyros VG, Mikhailidis DP, Elisaf MS.

Int J Clin Pract. 2007 Apr;61(4):545-51.

PMID:
17394429
18.

Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.

Utzschneider KM, Van de Lagemaat A, Faulenbach MV, Goedecke JH, Carr DB, Boyko EJ, Fujimoto WY, Kahn SE.

Obesity (Silver Spring). 2010 Sep;18(9):1781-7. doi: 10.1038/oby.2010.77. Epub 2010 Apr 8.

19.

Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome.

Maggio AB, Mueller P, Wacker J, Viallon M, Belli DC, Beghetti M, Farpour-Lambert NJ, McLin VA.

J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):720-6. doi: 10.1097/MPG.0b013e318244a685.

PMID:
22157928
20.

The impact of metabolic syndrome on insulin sensitivity, glucose sensitivity, and acute insulin response after glucose load in early-onset type 2 diabetes mellitus: Taiwan Early-Onset Type 2 Diabetes Cohort Study.

Hsieh CH, Wu CZ, Hsiao FC, Lin JD, Li JC, Wan HL, Kuo SW, Hung YJ, Su CC, Pei D; Taiwan Early-Onset Type 2 Diabetes Cohort.

Metabolism. 2008 Nov;57(11):1615-21. doi: 10.1016/j.metabol.2008.07.017.

PMID:
18940402

Supplemental Content

Support Center